Conference
P071 Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn’s disease
Authors
Halder S; Khan W; Wang X; Kuhns S; Sweet H; Reinisch W; McBride H
Volume
13
Pagination
pp. s121-s121
Publisher
Oxford University Press (OUP)
Publication Date
January 25, 2019
DOI
10.1093/ecco-jcc/jjy222.195
Conference proceedings
Journal of Crohn's and Colitis
Issue
Supplement_1
ISSN
1197-4982